Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Molecular Endocrinology (Baltimore, Md.)|September 15, 2015
Minireview: Were the IGF Signaling Inhibitors All Bad?Heather Beckwith, Douglas Yee
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 10, 2014
Insulin-like growth factors, insulin, and growth hormone signaling in breast cancer: implications for targeted therapyHeather Beckwith, Douglas Yee
The Breast Journal|February 23, 2021
Synchronous breast carcinoma and peritoneal mesotheliomaSaranya Prathibha, Heather Beckwith, Robert A Kratzke, et al.
JNCI Cancer Spectrum|January 6, 2021
Sources of Medical Information for Oncology Physicians During the COVID-19 Pandemic: Results From a National Cross-Sectional SurveyHelen M Parsons, Rachel I Vogel, Anne H Blaes, et al.
Breast Cancer Research and Treatment|October 30, 2021
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancerJ Asher Jenkins, Schelomo Marmor, Jane Yuet Ching Hui, et al.
Archives of Pathology & Laboratory Medicine|March 13, 2018
Distribution of 21-Gene Recurrence Scores Among Breast Cancer Histologic SubtypesScott Kizy, Jing Li Huang, Schelomo Marmor, et al.
Breast Cancer Research and Treatment|August 13, 2017
Vascular function in breast cancer survivors on aromatase inhibitors: a pilot studyAnne Blaes, Heather Beckwith, Natalia Florea, et al.
Breast Cancer Research and Treatment|September 10, 2018
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinomaJing Li Huang, Scott Kizy, Schelomo Marmor, et al.
Pageof 3